Stocks · Financials · Investment Advice

Moelis & Co

MC Clue Score63
United States Fiscal year ends December CIK 0001596967 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Osamu R. Watanabe
19 Feb 2026
General Counsel, Secretary
Sold after exercise
2,765
$62.23
$172.07K
Navid Mahmoodzadegan
19 Feb 2025
Co-President, MD
Sold after exercise
9,406
$74.00
$696.04K
Osamu R. Watanabe
19 Feb 2025
General Counsel, Secretary
Sold after exercise
5,661
$74.00
$418.91K
Jeffrey Raich
19 Feb 2025
Co-President, MD
Sold after exercise
8,722
$74.00
$645.43K
Christopher Callesano
19 Feb 2025
Principal Accounting Officer
Sold after exercise
1,282
$74.00
$94.87K
Kenneth Moelis
19 Feb 2025
Chairman, CEO
Sold after exercise
9,712
$74.00
$718.69K
Joseph Simon
19 Feb 2025
Chief Financial Officer
Sold after exercise
5,758
$74.00
$426.09K
Eric Cantor
19 Feb 2025
Vice Chairman, MD
Sold after exercise
16,530
$74.00
$1.22M
Ciafone Katherine Pilcher
19 Feb 2025
Chief Operating Officer
Sold after exercise
3,515
$74.00
$260.11K
Joseph Simon
25 Jul 2024
Chief Financial Officer
Sold after exercise
6,723
$64.00
$430.27K
Kenneth Moelis
23 Feb 2024
Chairman, CEO
Sold after exercise
400
$55.00
$22.00K
Ciafone Katherine Pilcher
21 Feb 2024
Chief Operating Officer
Sold after exercise
4,798
$52.60
$252.37K
Osamu R. Watanabe
21 Feb 2024
General Counsel, Secretary
Sold after exercise
7,685
$52.60
$404.23K
Eric Cantor
21 Feb 2024
Vice Chairman, MD
Sold after exercise
17,857
$52.60
$939.28K
Kenneth Moelis
21 Feb 2024
Chairman, CEO
Sold after exercise
128,277
$52.60
$6.75M
Christopher Callesano
21 Feb 2024
Principal Accounting Officer
Sold after exercise
1,144
$52.60
$60.17K
Jeffrey Raich
21 Feb 2024
Co-President, MD
Sold after exercise
39,781
$52.60
$2.09M
Joseph Simon
21 Feb 2024
Chief Financial Officer
Sold after exercise
8,149
$52.60
$428.64K
Navid Mahmoodzadegan
21 Feb 2024
Co-President, MD
Sold after exercise
85,900
$52.60
$4.52M
Osamu R. Watanabe
22 Feb 2023
General Counsel, Secretary
Sold after exercise
5,716
$42.06
$240.41K
Elizabeth Crain
22 Feb 2023
Chief Operating Officer
Sold after exercise
10,419
$42.06
$438.22K
Navid Mahmoodzadegan
22 Feb 2023
Co-President, MD
Sold after exercise
68,561
$42.06
$2.88M
Kenneth Moelis
22 Feb 2023
Chairman, CEO
Sold after exercise
45,507
$42.06
$1.91M
Jeffrey Raich
22 Feb 2023
Co-President, MD
Sold after exercise
36,592
$42.06
$1.54M
Elizabeth Crain
22 Feb 2022
Chief Operating Officer
Sold after exercise
11,757
$47.12
$553.99K
Navid Mahmoodzadegan
22 Feb 2022
Co-President, MD
Sold after exercise
53,518
$47.12
$2.52M
Kenneth Moelis
22 Feb 2022
Chairman, CEO
Sold after exercise
34,370
$47.12
$1.62M
Jeffrey Raich
22 Feb 2022
Co-President, MD
Sold after exercise
33,762
$47.12
$1.59M
Osamu R. Watanabe
22 Feb 2022
General Counsel, Secretary
Sold after exercise
6,232
$47.12
$293.65K
Christopher Callesano
23 Feb 2021
Principal Accounting Officer
Sold after exercise
1,346
$50.05
$67.37K
Joseph Simon
23 Feb 2021
Chief Financial Officer
Sold after exercise
13,189
$53.00
$699.02K
Navid Mahmoodzadegan
27 Oct 2020
Co-President, MD
Sold after exercise indirect
106,583
$38.55
$4.11M
Navid Mahmoodzadegan
27 Oct 2020
Co-President, MD
Sold after exercise indirect
1,089,265
$38.55
$41.99M
Jeffrey Raich
27 Oct 2020
Co-President, MD
Sold after exercise indirect
54,802
$38.55
$2.11M
Jeffrey Raich
27 Oct 2020
Co-President, MD
Sold after exercise indirect
578,298
$38.55
$22.29M
Jeffrey Raich
27 Oct 2020
Co-President, MD
Sold after exercise
364
$38.55
$14.03K
Christopher Callesano
21 Feb 2020
Principal Accounting Officer
Sold after exercise
1,497
$36.75
$55.01K
Osamu R. Watanabe
20 Feb 2020
General Counsel, Secretary
Sold after exercise
8,667
$36.72
$318.25K
Kenneth Moelis
20 Feb 2020
Chairman, CEO
Sold after exercise
79,331
$36.72
$2.91M
Navid Mahmoodzadegan
20 Feb 2020
Co-President, MD
Sold after exercise
74,269
$36.72
$2.73M
Jeffrey Raich
20 Feb 2020
Co-President, MD
Sold after exercise
67,733
$36.72
$2.49M
Elizabeth Crain
20 Feb 2020
Chief Operating Officer
Sold after exercise
14,734
$36.72
$541.03K
Osamu R. Watanabe
7 Feb 2020
General Counsel, Secretary
Sold after exercise
10,000
$38.80
$388.00K
Osamu R. Watanabe
4 Nov 2019
General Counsel, Secretary
Sold after exercise
15,776
$35.33
$557.37K
Jeffrey Raich
1 Nov 2019
Co-President, MD
Sold after exercise
73,359
$34.35
$2.52M
Jeffrey Raich
1 Nov 2019
Co-President, MD
Sold after exercise
13,934
$34.27
$477.52K
Joseph Simon
29 Aug 2019
Chief Financial Officer
Sold after exercise
17,528
$33.64
$589.62K
Elizabeth Crain
3 Jun 2019
Chief Operating Officer
Sold after exercise indirect
698
$32.19
$22.47K
Elizabeth Crain
3 Jun 2019
Chief Operating Officer
Sold after exercise
9,302
$32.19
$299.43K
Elizabeth Crain
3 Jun 2019
Chief Operating Officer
Sold after exercise
9,669
$32.26
$311.91K
Elizabeth Crain
3 Jun 2019
Chief Operating Officer
Sold after exercise
12,000
$31.98
$383.80K
Christopher Callesano
3 May 2019
Principal Accounting Officer
Sold after exercise
3,500
$38.00
$133.00K
Kenneth Moelis
1 May 2019
Chairman, CEO
Sold after exercise
84,708
$37.50
$3.18M
Jeffrey Raich
1 May 2019
Co-President, MD
Sold after exercise
73,361
$37.50
$2.75M
Navid Mahmoodzadegan
1 May 2019
Co-President, MD
Sold after exercise
73,361
$37.50
$2.75M
Osamu R. Watanabe
1 May 2019
General Counsel, Secretary
Sold after exercise
16,972
$37.50
$636.45K
Elizabeth Crain
1 May 2019
Chief Operating Officer
Sold after exercise
16,971
$37.50
$636.41K
Elizabeth Crain
15 May 2018
Chief Operating Officer
Sold after exercise
6,668
$57.24
$381.70K
Joseph Simon
14 May 2018
Chief Financial Officer
Sold after exercise
1,263
$56.72
$71.63K
Jeffrey Raich
14 May 2018
MD & Co-President
Sold after exercise
5,247
$56.46
$296.24K
Jeffrey Raich
14 May 2018
MD & Co-President
Sold after exercise
1,720
$56.76
$97.62K
Kenneth Moelis
1 May 2018
Chairman and CEO
Sold after exercise
228
$54.00
$12.31K
Kenneth Moelis
30 Apr 2018
Chairman and CEO
Sold after exercise
8,000
$54.00
$432.00K
Christopher Callesano
25 Apr 2018
ED & Principal Acct Officer
Sold after exercise
1,750
$54.25
$94.94K
Christopher Callesano
25 Apr 2018
ED & Principal Acct Officer
Sold after exercise
1,585
$54.25
$85.99K
Osamu R. Watanabe
24 Apr 2018
General Counsel and Secretary
Sold after exercise
2,312
$54.45
$125.89K
Kenneth Moelis
24 Apr 2018
Chairman and CEO
Sold after exercise
17,785
$54.45
$968.39K
Jeffrey Raich
24 Apr 2018
MD & Co-President
Sold after exercise
13,339
$54.45
$726.31K
Navid Mahmoodzadegan
24 Apr 2018
MD & Co-President
Sold after exercise
13,339
$54.45
$726.31K
Elizabeth Crain
24 Apr 2018
Chief Operating Officer
Sold after exercise
4,535
$54.45
$246.93K
J Richard Leaman III
24 Apr 2018
MD & Vice Chairman
Sold after exercise
8,003
$54.45
$435.76K
Osamu R. Watanabe
22 Feb 2018
General Counsel and Secretary
Sold after exercise
5,185
$50.00
$259.25K
Kenneth Moelis
22 Feb 2018
Chairman and CEO
Sold after exercise
49,116
$50.00
$2.46M
Jeffrey Raich
22 Feb 2018
MD & Co-President
Sold after exercise
43,470
$50.00
$2.17M
Navid Mahmoodzadegan
22 Feb 2018
MD & Co-President
Sold after exercise
43,470
$50.00
$2.17M
Elizabeth Crain
22 Feb 2018
Chief Operating Officer
Sold after exercise
8,583
$50.00
$429.15K
J Richard Leaman III
22 Feb 2018
MD & Vice Chairman
Sold after exercise
15,572
$50.00
$778.60K
Joseph Simon
22 Feb 2018
Chief Financial Officer
Sold after exercise
2,528
$50.00
$126.40K
Joseph Simon
9 May 2017
Chief Financial Officer
Sold after exercise
1,263
$38.40
$48.50K
Christopher Callesano
27 Apr 2017
SVP & Principal Acct Officer
Sold after exercise
1,750
$38.62
$67.58K
Christopher Callesano
27 Apr 2017
SVP & Principal Acct Officer
Sold after exercise
1,783
$38.62
$68.85K
Jeffrey Raich
27 Apr 2017
MD & Co-President
Sold after exercise
6,967
$38.55
$268.58K
Christopher Callesano
26 Apr 2017
SVP & Principal Acct Officer
Sold after exercise
1,382
$38.12
$52.68K
Osamu R. Watanabe
26 Apr 2017
General Counsel and Secretary
Sold after exercise
4,225
$38.12
$161.06K
J Richard Leaman III
26 Apr 2017
MD & Vice Chairman
Sold after exercise
14,626
$38.12
$557.54K
Elizabeth Crain
26 Apr 2017
Chief Operating Officer
Sold after exercise
8,288
$38.12
$315.94K
Navid Mahmoodzadegan
26 Apr 2017
MD & Co-President
Sold after exercise
24,378
$38.12
$929.29K
Jeffrey Raich
26 Apr 2017
MD & Co-President
Sold after exercise
24,378
$38.12
$929.29K
Showing 250 of 260 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 843
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 98
Sales at will 156
Transactions with no price 0
Shares from compensation/vesting 8,343,480
Sales filed before the plan box existed 120
History held since 17 Apr 2014